Login  
All Available CME Activities
Multimedia | CME From JCP | JCP Supplement | CME From PCC

MultimediaHispanics are the most prevalent and diverse minority group in the US, and treating Hispanic adults for ADHD can be difficult. Read this Psychlopedia to learn about the unique characteristics and needs of Hispanic individuals with ADHD and use this knowledge to provide culturally competent diagnosis and treatment. [top]

Challenges in the Recognition and Management of ADHD in Hispanic Adults in the United States

Culturally Competent Approaches to Diagnosing ADHD in Hispanic Adults and Overcoming Cultural Issues With Patients and Families

Juan Pedraza, MD

Health Care Systems Issues and Disparities in ADHD Care for Hispanic Adults

Yamalis Diaz, PhD

Overcoming Challenges in the Diagnosis and Management of ADHD in African American Adults

Culturally Competent Approaches to Assessing ADHD in African American Adults and Overcoming Cultural Issues With Patients and Families

Roberta Waite, EdD, PMHCNS-BC, FAAN

Health Care Systems Issues and Disparities in ADHD Care for African American Adults

J. Russell Ramsay, PhD

Controversies in the Psychopharmacology of Bipolar Disorder

Controversies in the Psychopharmacology of Bipolar Disorder

Robert M. Post, MD (Chair), et al

Poster Sessions From The 2014 ASCP Annual Meeting

2014 ASCP Annual Meeting Poster Session 4

Various Presenters

2014 ASCP Annual Meeting Poster Session 3

Various Presenters

2014 ASCP Annual Meeting Poster Session 2

Various Presenters

2014 ASCP Annual Meeting Poster Session 1

Various Presenters

Appropriate Management of Multiple Sclerosis in Primary Care: Focus on Rural Health

Developing a Therapeutic Plan for MS: Evidence for New Treatments

Michael C. Levin, MD, and W. Clay Jackson, MD, DipTh

Diagnosing MS: Recognizing Common Symptoms and Interpreting MRI Results

Michael C. Levin, MD, and W. Clay Jackson, MD, DipTh

The Impact of Oral Medications on the Treatment of Multiple Sclerosis

Recognizing and Overcoming Potential Barriers to Oral Medications for MS

Harold Moses, Jr, MD

Current Standards of Treatment in MS and the Role of Oral Agents

Harold Moses, Jr, MD

Measurement-Based Strategies to Assess and Manage Schizophrenia

New Treatment Targets to Improve Symptoms in Schizophrenia

Leslie Citrome, MD, MPH

Assessing Disability in Schizophrenia: Tools and Contributors

Philip D. Harvey, PhD

Recognizing Primary Vs Secondary Negative Symptoms and Apathy Vs Expression Domains

Brian Kirkpatrick, MD, MSPH

Making Connections Between Science and Symptoms in Schizophrenia

The Role of NMDA Receptors in Schizophrenia

John M. Kane, MD

Schizophrenia: Overview and Dopamine Dysfunction

Anissa Abi-Dargham, MD

Mechanism of Action of Antipsychotic Medications

Christoph U. Correll, MD

The Glutamate Hypothesis of Schizophrenia

Jonathan M. Meyer, MD

Benefits and Barriers to Using Long-Acting Injectable Antipsychotics in Schizophrenia

The Role of the Extended Health Care Team in Successful LAI Therapy: Education to Overcome Barriers

Christoph U. Correll, MD

Recognition of Patients Who Would Benefit From LAI Antipsychotic Treatment: How to Assess Adherence

Christoph U. Correll, MD

Attitudinal Barriers to Prescribing LAI Antipsychotics in the Outpatient Setting: Communicating With Patients, Families, and Caregivers

John M. Kane, MD

Update on Treatment-Resistant Depression: Translating Clinical Science Into Effective Therapies

Update on Treatment-Resistant Depression: Translating Clinical Science Into Effective Therapies

Michael E. Thase, MD

Improving the Differential Diagnosis and Treatment of Bipolar Depression in Primary Care

Prescribing Antidepressants for Bipolar Depression: What Does the Evidence Say?

Susan L. McElroy, MD

Differential Diagnosis of Unipolar Vs Bipolar Depression

Larry Culpepper, MD, MPH

Improving the Diagnosis and Management of Depression in Bipolar Disorder

Monitoring Pharmacotherapy Response, Safety, and Tolerability to Enhance Adherence in Bipolar Disorder

Paul E. Keck, Jr., MD

Improving the Early Recognition and Diagnosis of Bipolar Disorder

Roger S. McIntyre, MD, FRCPC

Restless Legs Syndrome: Recognition, Diagnosis, and Treatment of a Common Sleep Disorder

Latest Guidelines and Advances for Treatment of Restless Legs Syndrome

Christopher J. Earley, MBBCh, PhD, FRCPI

Common Comorbidities and Differential Diagnosis of Restless Legs Syndrome

William G. Ondo, MD

Screening for Sleep Disorders: Recognizing the Features and Presentations of Restless Legs Syndrome

Richard P. Allen, PhD

Working Together to Restore Mental Well-Being and Address Domestic Violence Among Veterans: A Call to Action

Working Together to Address Domestic Violence Among Veterans

Casey T. Taft, PhD

Assessing and Managing Pain and Major Depression With Medical Comorbidities

Assessing and Managing Pain and Major Depression With Medical Comorbidities

W. Clay Jackson, MD, DipTh

Complicated OCD: Issues of Comorbidity and Clinical Challenges

Obsessive-Compulsive Disorder in Youth: Assessment and Treatment

Jennifer G. Wells, MSW, LISW

Presentation and Treatment of Complicated Obsessive-Compulsive Disorder

Charles F. Brady, PhD, ABPP

Obsessive-Compulsive Disorder and Common Comorbidities

Charles F. Brady, PhD, ABPP

Depression: Addressing Partial Response After First-Line Antidepressant Treatment

Strategies for Achieving Full Remission When First-Line Antidepressants Are Not Enough

Andrew A. Nierenberg, MD

Assessing Response to Treatment and Recognizing Residual Depressive Symptoms

Maurizio Fava, MD

Residual Symptoms and the Risk of Relapse in Major Depression

Michael E. Thase, MD

Schizophrenia: Using Long-Acting Injectable Antipsychotics to Improve Treatment Adherence and Outcomes

Monitoring Treatment and Managing Adherence in Schizophrenia

Stephen R. Marder, MD

Improving Patient Outcomes in Schizophrenia: Achieving Remission, Preventing Relapse, and Measuring Success

John M. Kane, MD

Addressing Barriers to Using Long-Acting Injectable Antipsychotics and Appropriately Monitoring Antipsychotic Adverse Effects

Christoph U. Correll, MD

The Effects of the Affordable Care Act on the Practice of Psychiatry

The Affordable Care Act and Practice in Psychiatry

Michael H. Ebert, MD (Chair), et al

ADHD in College, Phase II: Managing the Risk of Misuse, Abuse, and Diversion

Strategies for Managing the Risks Associated With ADHD Medications

J. Sloan Manning, MD

Recognizing and Addressing Barriers to the Effective Management of ADHD in College Students

Larry Culpepper, MD, MPH

Update on Best Practices for Managing Bipolar Depression

Important Distinctions Between Bipolar I and Bipolar II Depression

Terence A. Ketter, MD

Unmet Needs in the Assessment and Management of Bipolar I Depression

Gary S. Sachs, MD

Alzheimer's Disease: The Importance of Early Diagnosis and Appropriate Management

Early Diagnosis and Management of Alzheimer's Disease

Pierre N. Tariot, MD

Alzheimer's Disease: The Importance of Early Diagnosis and Appropriate Management

Pierre N. Tariot, MD, and P. Murali Doraiswamy, MBBS, FRCP

Caring for Returning Veterans: Meeting Mental Health Needs

Mental Health Needs of Returning Veterans

Terence M. Keane, PhD (Chair), et al

Military- and Sports-Related Mild Traumatic Brain Injury: Clinical Presentation, Management, and Long-Term Consequences

Military- and Sports-Related Mild Traumatic Brain Injury: An Overview

Elaine R. Peskind, MD (Chair), et al

Treatment of Depression in Primary Care: Using Tools to Improve Outcomes

Improving Patient Outcomes in Depression Through Guideline-Concordant, Measurement-Based Care

Larry Culpepper, MD, MPH

Evaluating and Monitoring Treatment Response in Depression Using Measurement-Based Assessment and Rating Scales

Madhukar H. Trivedi, MD

The Effect of Marijuana Use on the Risk for Schizophrenia

Does Using Marijuana Increase the Risk for Developing Schizophrenia?

A. Eden Evins, MD, MPH (Chair), et al

Depression, Pain, and Comorbid Medical Conditions

Depression, Pain, and Comorbid Medical Conditions

J. Sloan Manning, MD, and W. Clay Jackson, MD

Negative Symptoms in Schizophrenia: Treatment Gaps and Unmet Needs

Tools to Assess Negative Symptoms in Schizophrenia

John M. Kane, MD

Novel Pharmacologic Targets for the Treatment of Negative Symptoms in Schizophrenia

Robert W. Buchanan, MD

The Prevalence of Negative Symptoms in Schizophrenia and Their Impact on Patient Functioning and Course of Illness

Christoph U. Correll, MD

Understanding the Physiology of Schizophrenia

Brian Kirkpatrick, MD

Clinician Perceptions, Expectations, and Management of Negative Symptoms in Schizophrenia

Stephen R. Marder, MD

The Appropriate Use of Opiates in Chronic Pain

The Appropriate Use of Opiates in Chronic Pain

Autry J. Parker, MD, MPH

Multiple Sclerosis Syndromes and Symptoms: A Clinical Primer

Identifying and Treating Pain Caused by MS

Lance J. Wright, MD

A Fresh Look at Monoamine Oxidase Inhibitors for Depression

MAOIs: Issues in Treatment Adherence and Rates of Treatment Failure

Drs Cohen and Sclar

An Update on MAOIs: Dietary Restrictions and Drug Interactions

David A. Flockhart, MD, PhD

MAOIs and Transdermal Delivery

Chad M. VanDenBerg, PharmD, BCPP

Depression Epidemiology and Its Treatment Evolution

Robert M. A. Hirschfeld, MD

MAOIs and Depression Treatment Guidelines

Michael E. Thase, MD

The Use of MAOIs in Primary Care

Larry Culpepper, MD, MPH

Schizophrenia: When First-Line Treatment Fails

Addressing Nonresponse in Schizophrenia

John M. Kane, MD

Assessing and Measuring Nonresponse in Schizophrenia

John M. Kane, MD

New Treatment Approaches for Major Depressive Disorder

Understanding Antidepressant Mechanism of Action and Its Effect on Efficacy and Safety

Anita H. Clayton, MD

Applying Antidepressant Study Results to Clinical Practice

Michael E. Thase, MD

Advancing the Treatment of Depression With Personalized Medicine

Andrew A. Nierenberg, MD

Overview of Current Issues in the Management of Multiple Sclerosis

Treatment Options in Multiple Sclerosis

Emmanuelle Waubant, MD, PhD

Early Recognition and Diagnosis of Multiple Sclerosis

Emmanuelle Waubant, MD, PhD

ADHD in College: Seeking and Receiving Care During the Transition From Child to Adult

Identifying, Diagnosing, and Managing ADHD in College Students

Larry Culpepper, MD, MPH

Treating ADHD: Addressing the Needs of College Students

Larry Culpepper, MD, and Paul King, MD

CME From JCP New! Review the mechanism of action of available antipsychotics, learn why they're not effective for treating all symptoms, and find out about a potential treatment target. [top]

Making Connections Between Science and Symptoms in Schizophrenia

Schizophrenia: Mechanism of Action of Current and Novel Treatments

Christoph U. Correll, MD, and John M. Kane, MD

Schizophrenia: The Role of Dopamine and Glutamate

Anissa Abi-Dargham, MD, and Jonathan M. Meyer, MD

Working Together to Restore Mental Well-Being and Address Domestic Violence Among Veterans: A Call to Action

Preventing Domestic Violence in Families of Veterans

Jim Dao (moderator), et al

Journal CME Activities

Metabolic Syndrome in a French Cohort of Patients With Bipolar Disorder: Results From the FACE-BD Cohort

Ophélia Godin, Bruno Etain, Chantal Henry, Thierry Bougerol, Philippe Courtet, Leroux Mayliss, Christine Passerieux, Jean-Michel Azorin, Jean-Pierre Kahn, Sebastien Gard, Dominique Costagliola, and Marion Leboyer for the FondaMental Advanced Centers of Expertise in Bipolar Disorders (FACE-BD) Collaborators

Postdeployment Suicidal Ideations and Trajectories of Posttraumatic Stress Disorder in Danish Soldiers: A 3-Year Follow-Up of the USPER Study

Trine Madsen, Karen-Inge Karstoft, Mette Bertelsen, and Søren Bo Andersen

Demographic, Economic, and Clinical Correlates of Depression Treatment Response in an Underserved Primary Care Population

Dinesh Mittal, Lakshminarayana Chekuri, Liya Lu, and John C. Fortney

Prescription Drug Monitoring Program Inquiry in Psychiatric Assessment: Detection of High Rates of Opioid Prescribing to a Dual Diagnosis Population

Daniel T. Hackman, Marion S. Greene, Taya J. Fernandes, Ashley M. Brown, Eric R. Wright, and R. Andrew Chambers

Guidelines for Preventing Common Medical Complications of Catatonia: Case Report and Literature Review

Kimberly Clinebell, Pierre N. Azzam, Priya Gopalan, and Roger Haskett

Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression: A Systematic Review and Meta-Analysis

Bradley N. Gaynes, Stacey W. Lloyd, Linda Lux, Gerald Gartlehner, Richard A. Hansen, Shannon Brode, Daniel E. Jonas, Tammeka Swinson Evans, Meera Viswanathan, and Kathleen N. Lohr

The Impact of Cannabis and Stimulant Disorders on Diagnostic Stability in Psychosis

Grant E. Sara, Philip M. Burgess, Gin S. Malhi, Harvey A. Whiteford, and Wayne C. Hall

A Prospective 4-Year Naturalistic Follow-Up of Treatment and Outcome of 300 Bipolar I and II Patients

Christian Simhandl, Barbara König, and Benedikt L. Amann

Cause and Rate of Death in People With Schizophrenia Across the Lifespan: A Population-Based Study in Manitoba, Canada

Maia S. Kredentser, Patricia J. Martens, Harvey M. Chochinov, and Heather J. Prior

Long-Term Antidepressant Use and the Risk of Type 2 Diabetes Mellitus: A Population-Based, Nested Case-Control Study in Taiwan

Chi-Shin Wu, Susan Shur-Fen Gau, and Mei-Shu Lai

Do Benzodiazepines Reduce the Effectiveness of Exposure Therapy for Posttraumatic Stress Disorder?

Craig S. Rosen, Mark A. Greenbaum, Paula P. Schnurr, Tyson H. Holmes, Penny L. Brennan, and Matthew J. Friedman

Psychoeducational Interventions for Family Members of People With Schizophrenia: A Mixed-Method Systematic Review

Jacqueline Sin and Ian Norman

Posttraumatic Stress Disorder and Cognitive Function: Findings From the Mind Your Heart Study

Beth E. Cohen, MD, MAS (Chair), et al

Distinguishing Bipolar II Depression From Major Depressive Disorder With Comorbid Borderline Personality Disorder: Demographic, Clinical, and Family History Differences

Mark Zimmerman, Jennifer H. Martinez, Theresa A. Morgan, Diane Young, Iwona Chelminski, and Kristy Dalrymple

Impact of the Number of Parents With Alcohol Use Disorder on Alcohol Use Disorder in Offspring: A Population-Based Study

Gihyun Yoon, Joseph Westermeyer, Michael A. Kuskowski, and Laura Nesheim

Predicting Diagnostic Change Among First-Episode Patients Diagnosed With DSM-IV Major Depression With Psychotic Features

Paola Salvatore, Ross J. Baldessarini, Hari-Mandir K. Khalsa, Mario Amore, Cristina Di Vittorio, Gabriella Ferraro, Carlo Maggini, and Mauricio Tohen

Termination of Clozapine Treatment Due to Medical Reasons: When Is It Warranted and How Can It Be Avoided?

Jimmi Nielsen, Christoph U. Correll, Peter Manu, and John M. Kane

Is Depression With Atypical Features Associated With Trauma History?

Amy C. Withers, Jenna M. Tarasoff, and Jonathan W. Stewart

Five-Year Course of Obsessive-Compulsive Disorder: Predictors of Remission and Relapse

Jane L. Eisen, Nicholas J. Sibrava, Christina L. Boisseau, Maria C. Mancebo, Robert L. Stout, Anthony Pinto, and Steven A. Rasmussen

Clinician-Rated Versus Self-Rated Screening for Bipolar Disorder Among Inpatients With Mood Symptoms and Substance Misuse

Joseph F. Goldberg, Amir Garakani, and Sigurd H. Ackerman

Marital Status, Childhood Maltreatment, and Family Dysfunction: A Controlled Study of Pathological Gambling

Donald W. Black, Martha C. Shaw, Brett A. McCormick, and Jeff Allen

Panic Attacks as a Dimension of Psychopathology: Evidence for Associations With Onset and Course of Mental Disorders and Level of Functioning

Neeltje M. Batelaan, Didi Rhebergen, Ron de Graaf, Jan Spijker, Aartjan T. F. Beekman, and Brenda W. J. H. Penninx

Risk of Injurious Road Traffic Crash After Prescription of Antidepressants

Ludivine Orriols, Raphaëlle Queinec, Pierre Philip, Blandine Gadegbeku, Bernard Delorme, Nicholas Moore, Samy Suissa, and Emmanuel Lagarde for the CESIR Research Group

Adult Outcome of Attention-Deficit/Hyperactivity Disorder: A Controlled 16-Year Follow-Up Study

Joseph Biederman, Carter R. Petty, K. Yvonne Woodworth, Alexandra Lomedico, Laran L. Hyder, and Stephen V. Faraone

A Randomized Controlled Trial of Psychoeducation or Cognitive-Behavioral Therapy in Bipolar Disorder: A Canadian Network for Mood and Anxiety Treatments (CANMAT) Study

Sagar V. Parikh, Ari Zaretsky, Serge Beaulieu, Lakshmi N. Yatham, L. Trevor Young, Irene Patelis-Siotis, Glenda M. MacQueen, Anthony Levitt, Tamara Arenovich, Pablo Cervantes, Vytas Velyvis, Sidney H. Kennedy, and David L. Streiner

Managing Psychiatric Issues in Elite Athletes

Ira D. Glick, Mark A. Stillman, Claudia L. Reardon, and Eva C. Ritvo

Tobacco Use Before, At, and After First-Episode Psychosis: A Systematic Meta-Analysis

Nicholas Myles, Hannah D. Newall, Jackie Curtis, Olav Nielssen, David Shiers, and Matthew Large

How Successful Are Physicians in Eliciting the Truth From Their Patients? A Large-Scale Internet Survey From Patients’ Perspectives

Norifusa Sawada, Hiroyuki Uchida, Koichiro Watanabe, Toshiaki Kikuchi, Takefumi Suzuki, Haruo Kashima, and Masaru Mimura

Results of the Search for Personality Disorder Screening Tools: Clinical Implications

Sara Germans, Guus L. Van Heck, and Paul P. G. Hodiamont

The Role of Psychomotor Activation in Discriminating Unipolar From Bipolar Disorders: A Classification-Tree Analysis

Giovanni B. Cassano, Paola Rucci, Antonella Benvenuti, Mario Miniati, Simona Calugi, Luca Maggi, Stephano Pini, David J. Kupfer, Mario Maj, Andrea Fagiolini, and Ellen Frank

Increased Risk of Diabetes Mellitus Among Persons With Psychotic Symptoms: Results From the WHO World Health Survey

Roberto Nuevo, Somnath Chatterji, David Fraguas, Emese Verdes, Nirmala Naidoo, Celso Arango, and José Luis Ayuso-Mateos

Early and Delayed Onset of Response to Antidepressants in Individual Trajectories of Change During Treatment of Major Depression: A Secondary Analysis of Data From the Genome-Based Therapeutic Drugs for Depression (GENDEP) Study

Rudolf Uher, Ole Mors, Marcella Rietschel, Aleksandra Rajewska-Rager, Ana Petrovic, Astrid Zobel, Neven Henigsberg, Julien Mendlewicz, Katherine J. Aitchison, Anne Farmer, and Peter McGuffin

Depression: Addressing Partial Response After First-Line Antidepressant Treatment

Depression: Addressing Partial Response After First-Line Antidepressant Treatment

Michael E. Thase, MD (Chair), et al

The Effects of the Affordable Care Act on the Practice of Psychiatry

The Effects of the Affordable Care Act on the Practice of Psychiatry

Michael H. Ebert, MD (Chair), et al

Update on Best Practices for Managing Bipolar Depression

Update on Best Practices for Managing Bipolar Depression

Gary S. Sachs, MD, and Terence A. Ketter, MD

Caring for Returning Veterans: Meeting Mental Health Needs

Commentary: Caring for Returning Veterans: Meeting Mental Health Needs

Terence M. Keane, MD (Chair), et al

Military- and Sports-Related Mild Traumatic Brain Injury: Clinical Presentation, Management, and Long-Term Consequences

Commentary: Military- and Sports-Related Mild Traumatic Brain Injury: Clinical Presentation, Management, and Long-Term Consequences

Elaine R. Peskind, MD (Chair), et al

The Effect of Marijuana Use on the Risk for Schizophrenia

Commentary: The Effect of Marijuana Use on the Risk for Schizophrenia

A. Eden Evins, MD, MPH (Chair), et al

International Consensus Group on Depression Prevention in Bipolar Disorder

International Consensus Group on Depression Prevention in Bipolar Disorder

Mark A. Frye, MD (Chair), et al

JCP SupplementPersisting negative and cognitive symptoms negatively impact patients' functioning, quality of life, and chances for achieving recovery. In this Supplement, learn how to disinguish between primary and secondary negative symptoms, find out how to assess your patients' treatment response and functioning, and discover new therapeutic targets in the treatment of schizophrenia to comprehensively address all presentations of the disorder. [top]

Measurement-Based Strategies to Assess and Manage Schizophrenia

Measurement-Based Strategies to Assess and Manage Schizophrenia

Leslie Citrome, MD, MPH (Chair), et al

Depression: Managing the Full Range of Symptoms to Achieve Lasting Remission

Depression: Managing the Full Range of Symptoms to Achieve Lasting Remission

John M. Zajecka, MD (Chair), et al

A Fresh Look at Monoamine Oxidase Inhibitors for Depression

A Fresh Look at Monoamine Oxidase Inhibitors for Depression

Lawrence J. Cohen, PharmD, BCPP, FASHP, FCCP, FCP (Co-Chair), and David A. Sclar, BPharm, PhD (Co-Chair), et al

CME From PCCAntidepressants are used in up to 50% of patients with bipolar depression. Do you prescribe them for your patients? Read this brief review to find out whether antidepressants work in bipolar depression and whether any benefits exceed risks, such as induction of (hypo)mania and rapid cycling. [top]

Companion CME Activities

Review of Evidence for Use of Antidepressants in Bipolar Depression

Shane J. McInerney and Sidney H. Kennedy

A Cross-Sectional Study of Major Repeaters: A Distinct Phenotype of Suicidal Behavior

Hilario Blasco-Fontecilla, MD, PhD; Isabelle Jaussent, PhD; Emilie Olié, MD, PhD; Severine Béziat, MSc; Sebastien Guillaume, MD, Paula Artieda-Urrutia, Enrique Baca-Garcia, Jose de Leon, and Philippe Courtet

Pharmacologic Treatment of Dimensional Anxious Depression: A Review

Dawn F. Ionescu, Mark J. Niciu, Erica M. Richards, and Carlos A. Zarate, Jr

Mixed Specifier for Bipolar Mania and Depression: Highlights of DSM-5 Changes and Implications for Diagnosis and Treatment in Primary Care

Jia Hu, Rodrigo Mansur, and Roger S. McIntyre

Hypersexuality in Dementia

Anna D. Burke, Roy Yaari, Pierre N. Tariot, Adam S. Fleisher, Geri R. Hall, and Helle Brand

Preserving Independence

Roy Yaari, Anna D. Burke, Helle Brand, James D. Seward, and Pierre N. Tariot

A Rapid Turn of Events: Sudden Physical and Cognitive Decline

Roy Yaari, Susy Favaro, Anna D. Burke, Helle Brand, Adam S. Fleisher, James D. Seward, Jan Dougherty, and Pierre N. Tariot

As Time Goes By

Roy Yaari, Geri Hall, Helle Brand, Jan Dougherty, Adam S. Fleisher, James D. Seward, and Pierre N. Tariot

The Threat of Behavioral Changes in Dementia

Anna D. Burke, Roy Yaari, Pierre N. Tariot, Geri R. Hall, Jan Dougherty, Helle Brand, and Adam S. Fleisher

Delayed Cognitive Impairment After a Hypoxic Event

Roy Yaari, Helle Brand, James D. Seward, Anna D. Burke, Adam S. Fleisher, and Pierre N. Tariot

A Wolf in Sheep’s Clothing: When Behaviors Imply Dementia

Anna D. Burke, Roy Yaari, Geri Hall, Helle Brand, Pierre Tariot, Adam Fleisher, and Jan Dougherty

A Tale of Two Amyloid Positron Emission Tomography Scans in Patients With Mild Cognitive Impairment

Roy Yaari, Adam S. Fleisher, James D. Seward, Anna D. Burke, Helle Brand, and Pierre N. Tariot

The Shadow People: A Glimpse Into Dementia With Lewy Bodies

Anna D. Burke, Roy Yaari, Pierre N. Tariot, Jan Dougherty, Adam S. Fleisher, and Helle Brand

Falling Down

Roy Yaari, Helle Brand, Jan Dougherty, Anna D. Burke, Adam S. Fleisher, James D. Seward, and Pierre N. Tariot

Alone in the Home

Roy Yaari, Geri R. Hall, Helle Brand, James D. Seward, Anna D. Burke, Adam S. Fleisher, Jan Dougherty, and Pierre N. Tariot

Psychological Masquerade

Anna D. Burke, Roy Yaari, Helle Brand, James D. Seward, Adam S. Fleisher, Jan Dougherty, and Pierre N. Tariot

When Laughing Is No Joking Matter

Roy Yaari, Helle Brand, James D. Seward, Anna D. Burke, Adam S. Fleisher, Jan Dougherty, and Pierre N. Tariot

Treatment of Depression in Primary Care: Using Tools to Improve Outcomes

Using Measurement-Based Care With Patient Involvement to Improve Outcomes in Depression

Larry Culpepper, MD, MPH, and Madhukar H. Trivedi, MD

 
​​​
​​